InvestorsHub Logo

Rubyred77

06/10/21 3:15 PM

#313858 RE: plexrec #313854

Right now the bar is low for most of the diseases Anavex is targeting. Say we get approved for various diseases, you know how much data the next trial will have to collect to show that it is better than the current soc….?

Unless the FDA approves EVERYTHING straight to P4 confirmation trials.